Roivant Sciences Ltd.

NasdaqGS:ROIV Stock Report

Market Cap: US$9.0b

Roivant Sciences Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:ROIV Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
02 Jan 24SellUS$33,150,000Vivek RamaswamyIndividual3,000,000US$11.05
28 Sep 23SellUS$126,000,000SoftBank Investment Advisers (UK) LimitedCompany10,000,000US$12.60
28 Sep 23SellUS$115,500,000QVT Financial LPCompany10,000,000US$11.55
22 Jun 23SellUS$128,700,000Viking Global Investors LPCompany13,000,000US$9.90
22 Jun 23SellUS$129,999,982Sumitomo Chemical Company, LimitedCompany15,116,277US$8.60

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of ROIV?
Owner TypeNumber of SharesOwnership Percentage
Public Companies00%
State or Government157,8300.0196%
Private Companies6,354,4000.789%
VC/PE Firms73,031,6679.06%
General Public126,092,05015.6%
Hedge Funds136,088,74016.9%
Individual Insiders168,575,75120.9%
Institutions295,545,56836.7%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 6.3%.


Top Shareholders

Top 25 shareholders own 71.56% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
12.2%
Dan Oren
98,165,313US$1.1b0%no data
9.06%
SoftBank Investment Advisers (UK) Limited
73,031,667US$818.7m0%4.09%
8.61%
Viking Global Investors LP
69,368,961US$777.6m-5.54%2.78%
8.28%
QVT Financial LP
66,719,779US$747.9m-40.7%66.1%
6.63%
Vivek Ramaswamy
53,431,426US$599.0m2.89%no data
4.59%
FMR LLC
36,976,158US$414.5m-4.97%0.03%
2.58%
BlackRock, Inc.
20,805,601US$233.2m17.4%no data
2.36%
Rubric Capital Management LP
19,000,000US$213.0m81%6.83%
2.3%
Morgan Stanley Investment Management Inc.
18,507,020US$207.5m4.17%0.14%
1.7%
State Street Global Advisors, Inc.
13,727,418US$153.9m33%0.01%
1.69%
Wellington Management Group LLP
13,640,416US$152.9m-8.1%0.02%
1.57%
Patient Square Capital, LP
12,639,920US$141.7m0%100.0%
1.23%
Daniel Gold
9,913,706US$111.1m0%no data
1.06%
Two Seas Capital LP
8,508,223US$95.4m7.49%22.6%
0.94%
Baker Bros. Advisors LP
7,593,024US$85.1m-36.1%1.04%
0.91%
Farallon Capital Management, L.L.C.
7,336,000US$82.2m90.4%0.56%
0.88%
The Vanguard Group, Inc.
7,075,651US$79.3m26.3%no data
0.76%
Woodline Partners LP
6,151,767US$69.0m-14.3%0.75%
0.69%
Geode Capital Management, LLC
5,524,576US$61.9m5.87%0.01%
0.66%
Mayukh Sukhatme
5,309,683US$59.5m61.4%no data
0.65%
Adage Capital Management, L.P.
5,275,000US$59.1m-14.9%0.11%
0.6%
Anchorage Capital Group, L.L.C.
4,832,642US$54.2m0%8.63%
0.58%
Dexcel Ltd.
4,684,130US$52.5m0%no data
0.58%
Avoro Capital Advisors LLC
4,651,162US$52.1m0%0.75%
0.47%
T. Rowe Price Group, Inc.
3,786,613US$42.4m-73.6%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.